过敏性鼻炎治疗市场：按治疗类型、给药途径、分销渠道、地区 - 规模、份额、前景和机会分析，2022-2030 年

过敏性鼻炎是一种由 IgE 介导的疾病，由过敏原引起，例如霉菌和鼻涕、动物皮屑、□虫、杂草花粉和草。 有两种类型的过敏性鼻炎，季节性和常年性，它们会在鼻子中引起轻度、中度至重度炎症。 过敏性鼻炎的主要症状包括鼻塞、流鼻涕、打喷嚏、鼻痒、眼睛发痒、鼻塞、头痛、鼻子和脸颊有压迫感、耳朵充血、喉咙痛、流泪、充血、浮肿、黑眼圈在眼睛和气味下。 过敏性鼻炎也可能与哮喘和湿疹并存。 过敏性鼻炎和鼻窦炎是有关係的，因为过敏性鼻炎堵住了鼻子，堵住了鼻窦。 过敏性鼻炎有多种治疗方法，包括类固醇喷雾剂、抗组胺药、减充血剂、白三烯抑製剂、过敏注射剂和舌下含片。 过敏性鼻炎可引起鼻息肉（鼻道和鼻窦中异常但非癌性的液囊）、鼻窦炎（由鼻子发炎或肿胀引起的感染）和中耳感染等并发症。

市场动态

为推进过敏原免疫疗法研究而加强的研究合作预计将在预测期内推动市场增长。 例如，2021 年 7 月，全球领先的过敏原免疫疗法医疗保健公司之一 Stallergenes Greer 宣布与位于法国斯特拉斯堡大学医院的合同研究机构 Alyatec 开展研究合作。 通过此次合作，Starergenes Glia 将利用 Ariatech 在研究和临床服务方面的能力，专注于基于精准医学的方法和过敏患者的管理。

这项研究的主要特点

• 本报告对全球过敏性鼻炎药物市场进行了深入分析，显示了以 2021 年为基准年的预测期 (2022-2030) 的市场规模和復合年增长率 (CAGR%)。I'我在这里。
• 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 根据公司亮点、产品组合、主要亮点、绩效和战略等参数介绍全球过敏性鼻炎治疗市场主要参与者的概况。
• 本研究涵盖的主要公司包括Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc. Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Glenmark Pharmaceuticals Ltd, Himalaya Wellness Company, Regeneron Pharmaceuticals Inc., Allergy Therapeutics, Stallergenes Greer, Bayer AG, Dr. Reddy's Laboratories Ltd, ALK-Abello A/S, Revolo Biotherapeutics among other prominent players 等知名企业
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
• 《全球过敏性鼻炎治疗药物市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球过敏性鼻炎治疗市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按治疗类型分类
  • 按给药途径划分的市场概况
  • 市场概况：按销售渠道
  • 市场概况：按地区
• 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场机会
• 影响分析
• 市场趋势
• 近期趋势
• 收购和合作场景
• 给药途径总结
• 监管场景
• 品牌分析
• 害虫分析
• 搬运工分析

第 4 章。过敏性鼻炎治疗的全球市场——冠状病毒 (COVID-19) 大流行的影响

• 总体影响
• 对供需的影响
• COVID-19 对市场的影响

第 5 章全球过敏性鼻炎药物市场：按治疗类型分类，2017-2030

• 免疫疗法
• 科学与技术学院
• SLITD
• 斯利特
• 抗组胺药
• 减充血剂
• 白三烯受体拮抗剂
• 肾上腺皮质类固醇

第 6 章全球过敏性鼻炎药物市场：按给药途径，2017-2030

• 口服剂
• 鼻内
• 眼内
• 静脉给药

第 7 章。过敏性鼻炎治疗的全球市场：按分销渠道，2017-2030

• 零售药房
• 医院药房
• 电子商务

第 8 章过敏性鼻炎治疗的全球市场：（按地区）2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章竞争格局

• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• AstraZeneca
• GSK plc.
• Johnson & Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Mylan N.V.
• Aytu BioPharma, Inc.
• Glenmark Pharmaceuticals Ltd
• Himalaya Wellness Company
• Regeneron Pharmaceuticals Inc.
• Allergy Therapeutics
• Stallergenes Greer
• Bayer AG
• Dr. Reddy's Laboratories Ltd.
• ALK-Abello A/S
• Revolo Biotherapeutics

第 10 章

• 调查方法
• 关于出版商

Allergic rhinitis or hay fever is an IgE-mediated disorder caused by allergens such as mold or tress, animal, dander, house dust mites, weed pollens, and grass. It can occur in two different forms namely, seasonal and perennial, which in turn causes mild or moderate to severe inflammation inside the nose. Some of the major symptoms of allergic rhinitis include nasal congestion, rhinorrhea, sneezing, nasal itching, itchy eyes, stuffy nose, headache, pressure in the nose and cheeks, ear fullness and popping, sore throat, watery, red, or swollen eyes, dark circles under your eyes, trouble smelling, etc. Allergic rhinitis can also be associated with asthma and eczema. Allergic rhinitis and sinusitis are linked to each other, as allergic rhinitis blocks the nose, which in turn blocks the sinuses. Various treatments are available for allergic rhinitis which includes nasal steroid sprays, antihistamines, decongestants, leukotriene inhibitors, allergy shots or sublingual tablets, etc. Allergic rhinitis can lead to complications in some cases such as nasal polyps- abnormal but non-cancerous (benign) sacs of fluid that grow inside the nasal passages and sinuses, sinusitis - an infection caused by nasal inflammation and swelling and middle ear infections.

Market Dynamics

Increasing collaborations for advancing research in allergen immunotherapy is expected to propel the market growth during the forecast period. For instance, in July 2021, Stallergenes Greer, one of the global healthcare companies specializing in allergen immunotherapy, announced a research collaboration with Alyatec, a contract research organization based in Strasbourg University Hospital (France). In this collaboration, Stallergenes Greer is focused on a precision medicine-based approach and the management of patients with allergies with the help of Alyatec's competencies in research and clinical services.

Key features of the study:

• This report provides in-depth analysis of the global allergic rhinitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global allergic rhinitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc. Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Glenmark Pharmaceuticals Ltd, Himalaya Wellness Company, Regeneron Pharmaceuticals Inc., Allergy Therapeutics, Stallergenes Greer, Bayer AG, Dr. Reddy's Laboratories Ltd, ALK-Abello A/S, Revolo Biotherapeutics among other prominent players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global allergic rhinitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market

Detailed Segmentation:

• Global Allergic Rhinitis Treatment Market, By Treatment Type:
  • Immunotherapy
    • SCIT
    • SLITD
    • SLITT
  • Anti-histamines
  • Decongestants
  • Leukotriene Receptor Antagonists
  • Corticosteroids
• Global Allergic Rhinitis Treatment Market, By Route of Administration:
  • Oral
  • Nasal
  • Intraocular
  • Intravenous
• Global Allergic Rhinitis Treatment Market, By Distribution Channel:
  • Retail Pharmacies
  • Hospital Pharmacies
  • E-commerce
• Global Allergic Rhinitis Treatment Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Merck & Co., Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • GSK plc.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Aytu BioPharma, Inc.
  • Glenmark Pharmaceuticals Ltd
  • Himalaya Wellness Company
  • Regeneron Pharmaceuticals Inc.
  • Allergy Therapeutics
  • Stallergenes Greer, Bayer AG
  • Bayer AG
  • Reddy's Laboratories Ltd
  • ALK-Abello A/S
  • Revolo Biotherapeutics

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Route of Administration Overview
• Regulatory Scenario
• Brand Analysis
• PEST Analysis
• Porter's Analysis

4. Global Allergic Rhinitis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• SCIT
• SLITD
• SLITT
• Anti-histamines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Decongestants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Leukotriene Receptor Antagonists
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Nasal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Intraocular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Intravenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• E-Commerce
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Allergic Rhinitis Treatment Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boehringer Ingelheim International GmbH
• AstraZeneca
• GSK plc.
• Johnson & Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Mylan N.V.
• Aytu BioPharma, Inc.
• Glenmark Pharmaceuticals Ltd
• Himalaya Wellness Company
• Regeneron Pharmaceuticals Inc.
• Allergy Therapeutics
• Stallergenes Greer
• Bayer AG
• Dr. Reddy's Laboratories Ltd.
• ALK-Abello A/S
• Revolo Biotherapeutics

10. Section

• Research Methodology
• About Us